These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 15579493

  • 1. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep.
    McLennan DN, Porter CJ, Edwards GA, Martin SW, Heatherington AC, Charman SA.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493
    [Abstract] [Full Text] [Related]

  • 2. The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep.
    McLennan DN, Porter CJ, Edwards GA, Heatherington AC, Martin SW, Charman SA.
    Pharm Res; 2006 Sep; 23(9):2060-6. PubMed ID: 16951999
    [Abstract] [Full Text] [Related]

  • 3. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.
    Charman SA, McLennan DN, Edwards GA, Porter CJ.
    Pharm Res; 2001 Nov; 18(11):1620-6. PubMed ID: 11758772
    [Abstract] [Full Text] [Related]

  • 4. Lymphatic route of transport and pharmacokinetics of Micrurus fulvius (coral snake) venom in sheep.
    Paniagua D, Jiménez L, Romero C, Vergara I, Calderón A, Benard M, Bernas MJ, Rilo H, de Roodt A, D' Suze G, Witte MH, Boyer L, Alagón A.
    Lymphology; 2012 Dec; 45(4):144-53. PubMed ID: 23700761
    [Abstract] [Full Text] [Related]

  • 5. Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection.
    Charman SA, Segrave AM, Edwards GA, Porter CJ.
    J Pharm Sci; 2000 Feb; 89(2):168-77. PubMed ID: 10688746
    [Abstract] [Full Text] [Related]

  • 6. Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model.
    Kota J, Machavaram KK, McLennan DN, Edwards GA, Porter CJ, Charman SA.
    Drug Metab Dispos; 2007 Dec; 35(12):2211-7. PubMed ID: 17875672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
    Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ.
    J Clin Pharmacol; 2004 Sep; 44(9):991-1002. PubMed ID: 15317827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects.
    Krzyzanski W, Jusko WJ, Wacholtz MC, Minton N, Cheung WK.
    Eur J Pharm Sci; 2005 Nov; 26(3-4):295-306. PubMed ID: 16102948
    [Abstract] [Full Text] [Related]

  • 16. Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogs.
    Wang W, Chen N, Shen X, Cunningham P, Fauty S, Michel K, Wang B, Hong X, Adreani C, Nunes CN, Johnson CV, Yin KC, Groff M, Zou Y, Liu L, Hamuro L, Prueksaritanont T.
    Drug Metab Dispos; 2012 May; 40(5):952-62. PubMed ID: 22328584
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats.
    Dahlberg AM, Kaminskas LM, Smith A, Nicolazzo JA, Porter CJ, Bulitta JB, McIntosh MP.
    Mol Pharm; 2014 Feb 03; 11(2):496-504. PubMed ID: 24350780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.